The incidence and prevalence of multiple sclerosis (MS) varies geographically as shown through extensive epidemiological studies performed mainly in developed countries. Nonetheless, scant data is available in Latin America and the Caribbean (LAC). The objective of this review is to assess epidemiological data of MS in LAC. We conducted a systematic review of published articles and gray literature from January 1995 to May 2011. Twenty-two studies met the inclusion criteria after full-text review. Incidence data were found in only three studies and ranged from 0.3 to 1.9 annual cases per 100,000 person-years. Prevalence was reported in 10 studies and ranged from 0.83 to 21.5 cases per 100,000 inhabitants. The most prevalent subtype of MS was the relapsing–remitting form (48% to 91% of the series). No data about mortality were found. This study showed low frequency for MS in LAC compared with North American and European countries. The role of environmental and genetic factors should be well studied, providing new insights about its etiology.
RosatiGThe prevalence of multiple sclerosis in the world: An update. Neurol Sci2001; 22: 117–139.
5.
CorrealeJEpidemiology of MS in Latin America. Mult Scler2009; S15.
6.
CristianoEPatruccoLGiuntaD. Incidence of multiple sclerosis in Buenos Aires: A 16-year health maintenance organization-based study. Eur J Neurol2010; 17: 479–482.
7.
BarahonaJMonteroAFloresAMultiple sclerosis in Chile. Arq Neuropsiquiatr2004; 62: 11.
8.
CallegaroDGoldbaumMMoraisL. The prevalence of multiple sclerosis in the city of São Paulo, Brazil, 1997. Acta Neurol Scand2001; 104: 208–213.
9.
CoronaTRomanGCMultiple sclerosis in Latin America. Neuroepidemiology2006; 26: 1–3.
10.
PugliattiMRiiseTSotgiuMA. Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology2005; 25: 129–134.
11.
LiberatiAAltmanDGTetzlaffJ. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med2009; 6: e1000100.
12.
StroupDFBerlinJAMortonSC. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA2000; 283: 2008–2012.
13.
LublinFDReingoldSCDefining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996; 46: 907–911.
14.
McDonaldWICompstonAEdanG. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
15.
PoserCMPatyDWScheinbergL. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol1983; 13: 227–231.
16.
PolmanCHReingoldSCEdanG. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”Ann Neurol2005; 58: 840–846.
17.
PolmanCHReingoldSCBanwellB. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2010; 69: 292–302.
18.
von ElmEAltmanDGEggerM. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet2007; 370: 1453–1457.
19.
FowkesFGFultonPMCritical appraisal of published research: Introductory guidelines. BMJ1991; 302: 1136–1140.
20.
EggerMDavey SmithG. Bias in meta-analysis detected by a simple, graphical test. BMJ1997; 315: 629–634.
21.
DerSimonianRLairdNMeta-analysis in clinical trials. Control Clin Trials1986; 7: 177–188.
22.
TakkoucheBCadarso-SuarezCSpiegelmanDEvaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol1999; 150: 206–215.
23.
AbadPPerezMCastroE. Prevalence of multiple sclerosis in Ecuador. Neurologia2010; 25: 309–313.
24.
CabrePSignateAOlindoS. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain2005; 128: 2899–2910.
25.
CristianoEPatruccoLRojasJI. Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method. Eur J Neurol2009; 16: 183–187.
26.
FragosoYDPeresMPrevalence of multiple sclerosis in the city of Santos, SP. Rev Bras Epidemiol2007; 10: 479–482.
27.
GraciaFCastilloLCBenzadonA. Prevalence and incidence of multiple sclerosis in Panama (2000–2005). Neuroepidemiology2009; 32: 287–293.
28.
MelconMOGoldLCarraA. Argentine Patagonia: Prevalence and clinical features of multiple sclerosis. Mult Scler2008; 14: 656–662.
29.
SanchezJLAguirreCArcos-BurgosOM. Prevalencia de la esclerosis multiple en Colombia. Rev Neurologia2000; 31: 1101–1103.
30.
ToroJSarmientoOLDíaz del CastilloA. Prevalence of multiple sclerosis in Bogotá, Colombia. Neuroepidemiology2007; 28: 33–38.
31.
Vizcarra EscobarDKawano CastilloJCastañeda BarbaC. Prevalencia de esclerosis múltiple en Lima — Perú. Rev Med Hered2009; 20: 146–150.
32.
Cabrera-GómezJAClinical characterization of patients with multiple sclerosis defined in Cuba [in Spanish]. Rev Neurol1998; 26: 723–728.
33.
Cabrera-GómezJALópez-SauraPAlpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba [in Spanish]. Rev Neurol1999; 28: 849–858.
34.
SanchezJLPalacioLGUribeCS. Clinical features of multiple sclerosis in a genetically homogeneous tropical population. Mult Scler2001; 7: 227–229.
35.
Alves-LeonSVMalfetanoFRPimentelMLV. Multiple sclerosis outcome and morbi-mortality of a Brazilian cohort patients. Arq Neuropsiquiatr2008; 66: 671–677.
36.
ArrudaWOScolaRHTeiveHAG. Multiple sclerosis: Report on 200 cases from Curitiba, Southern Brazil and comparison with other Brazilian series. Arq Neuropsiquiatr2001; 59: 165–170.
37.
FerreiraMLMachadoMIVilelaML. Epidemiology of 118 cases of multiple sclerosis after 15 years of follow-up on the reference center of Hospital da Restauração, Recife, Pernambuco, Brazil. Arq Neuropsiquiatr2004; 62: 1027–1032.
38.
CardosoEFukudaTPereiraJ. Clinical and epidemiological profile of multiple sclerosis in a reference center in the State of Bahia, Brazil. Arq Neuropsiquiatr2006; 64: 727–730.
39.
CórdovaJVargasSSoteloJWestern and Asian features of multiple sclerosis in Mexican Mestizos. Clin Neurol Neurosurg2007; 109: 146–151.
40.
FinkelsztejnACristovam RdoAMoraesGS. Clinical features of multiple sclerosis in the south of Brazil: A partial analysis. Arq Neuropsiquiatr2009; 67: 1071–1075.
41.
MoreiraMAFelipeEMendesMF. Esclerose múltipla: estudo descritivo de suas formas clínicas em 302 casos [Multiple sclerosis: Descriptive study of its clinical forms in 302 cases] [in Portuguese]. Arq Neuropsiquiatr2000; 58: 460–466.
42.
Velazquez-QuintanaMMacias-IslasMARivera-OlmosV. Multiple sclerosis in Mexico: A multicentre study. Rev Neurol2003; 36: 1019–1022.
43.
FerreiraMLBMachadoMMVilelaML. Epidemiologia de 118 casos de esclerose múltipla com seguimento de 15 anos no centro de referência do Hospital da Restauração de Pernambuco [Epidemiology of 118 cases of multiple sclerosis after 15 years of follow-up on the reference center of Hospital da Restauração, Recife, Pernambuco, Brazil] [in Portuguese]. Arq Neuropsiquiatr2004; 62: 1027–1032.
44.
EbersGCEnvironmental factors and multiple sclerosis. Lancet Neurol2008; 7: 268–277.
45.
AscherioAMungerKLEnvironmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol2007; 61: 504–513.
46.
CorrealeJYsrraelitMCGaitánMIImmunomodulatory effects of Vitamin D in multiple sclerosis. Brain2009; 132: 1146–1160.
47.
AscherioAMungerKLSimonKCVitamin D and multiple sclerosis. Lancet Neurol2010; 9: 599–612.
48.
BachJFThe effect of infections on susceptibility to autoimmune and allergic disease diseases. New Engl J Med2002; 347: 911–920.
49.
StrachanDPHay fever, hygiene and household size. BMJ1989; 299: 1259–1260.
50.
GorodezkyCCastro-EscobarLEEscobra-GutierrezAThe HLA system in the prevalent Mexican Indian group: The Nahuas. Tissue Antigens1985; 25: 38–46.
51.
MirsattariSMJohnstonJBMcKennaR. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology2001; 56: 317–323.
52.
KiraJMultiple sclerosis in the Japanese population. Lancet Neurol2003; 2: 117–127.
53.
Rivera-OlmosVMÁvilaMCEsclerosis múltiple en Latinoamérica. ¿Son los criterios de McDonald realmente aplicables? [in Spanish]. Rev Mex Neuroci2007; 8: 49–56.
54.
RiscoJMaldonadoHLunaL. Latitudinal prevalence gradient of multiple sclerosis in Latin America. Mult Scler2011; 17: 1055–1059.
DíazVBarahonaJAntinaoJ. Incidence of multiple sclerosis in Chile: A hospital registry study. Acta Neurol Scand2012; 125: 71–75.
59.
MelconMOMelconCBartoloniL. Towards establishing MS prevalence in Latin America and the Caribbean. Mult Scler. Epub ahead of print 4April2012.
60.
OrtonSMHerreraBMYeeIM. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol2006; 5: 932–936.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
